A neuro-technology company has received Food and Drug Administration (FDA) clearance for a medical device that could detect concussions in less than 60 seconds on the sidelines of playing fields across the nation. EYE-SYNC, a product of SyncThink, is an integrated head-mounted eye-tracking device that analyzes eye movement impairment through the use of virtual reality. Dr. Jamshid Ghajar, neurosurgeon at Stanford University, president of the Brain Trauma Foundation, and SyncThink founder, told FoxNews.com the product is distinct mainly because it does not claim to diagnose a concussion but rather detects disruption in visual information. "All of the other technologies out there say that they're'diagnosing concussion,' but there's no accepted definition, so how are you diagnosing it?" he said. Data released by the National Football League (NFL) in January revealed the rate of concussions in the 2015 season was up nearly 32 percent compared with data from 2014, while the Centers for Disease Control and Prevention (CDC) reports that each year nearly 500,000 children are treated for a traumatic brain injury, including concussion.